Reports on the application issued by Barr Pharmaceuticals for the U.S. Food and Drug Administration (FDA) to grant over-the-counter (OTC) status to Plan B emergency contraceptives. Reason for the rejection of FDA to the OTC status application; Recommendations issued by FDA for the approval of the OTC status application; Values associated with FDA rejection.